Close
ACHEMA MIDDLE EAST 2026

Guangzhou Medical University & AstraZeneca: Advancing understanding of COPD in China

AI Summary

We’re working with Guangzhou Medical University, one of the world’s leading centres for research into respiratory disease, to advance the scientific understanding of Chronic Obstructive Pulmonary Disease (COPD).

Our team had previously carried out COPD studies in many western countries and was interested in comparing earlier findings with those from China, where COPD prevalence is high and rising rapidly. 

Our aim was to find better ways of diagnosing and preventing incidence.

The GMU hospital’s laboratory of respiratory disease conducted a two-year study into the reasons for disease progression by observing over 300 COPD patients and comparing them with healthy controls

 

Senior pharmaceutical decision - makers don’t consume every piece of content. They have sources they trust. Pharma Advancement is one of them.

Reaching this audience means appearing where they already are — inside trusted editorial that covers the full pharmaceutical and life sciences value chain. Our 2026 Media Pack shows you where to be seen:

Magazine & Digital

Where pharmaceutical decision - makers go to understand what’s coming next. Your brand belongs in that conversation.

Insights & Reports

The analysis and research the sector references when it matters most. Being part of it positions you differently.

Brand Authority

The companies that show up consistently in trusted editorial don’t need to explain who they are. They already are.

SUBSCRIBE OUR NEWSLETTER

WHITE PAPERS

RELATED ARTICLES